What’s Going On With Mullen Automotive Shares Today?

Mullen Automotive, Inc. (NASDAQ: MULN) shares are trading 

Mullen Automotive, Inc. (NASDAQ:MULN) shares are trading lower on Tuesday morning. 

The company said it delivered 50 additional Class 1 EV cargo vans to Randy Marion Automotive Group, invoiced for $1.681 million.

Last week, the company revealed the delivery of 50 Class 1 EV Cargo Vans to Randy Marion Automotive Group for $1.680 million.

To date, the company has delivered 100 Mullen ONE, Class 1 cargo vans for a total invoiced amount of $3.36 million. 

Mullen is on target to deliver a total of 285 Class 1 vehicles by Jan. 8, 2024. 

RelatedEV Showdown 2024: Tesla, BYD, NIO, XPeng, Li – Which Offers Greater Value?

“We ended 2023 with an emphasis on delivering Class 1 and Class 3 vehicles and are now ramping up production to meet the commitments we have for the 2024 demands of our current and future customers,” said David Michery, CEO and chairman of Mullen Automotive.

Mullen recently announced the completed development of its solid-state polymer cell to pack integration for Mullen One Class 1 EV cargo vans. The company remains on schedule to begin on-vehicle road testing of the solid-state polymer packs in the Class 1 EV cargo van in early 2024.

Meanwhile, on Dec. 19, the company announced a 1-for-100 reverse stock split, effective Dec. 21, 2023, at 12:01 a.m., Eastern Time. 

Read Next: Why EV Behemoth NIO Shares Are Falling Today

Price Action: MULN shares are trading lower by 8.05% to $13.14 on the last check Tuesday. 

Photo via Company

Total
0
Shares
Related Posts
Read More

Genetic Technologies Limited Announces Publication Of Peer-Reviewed Research On geneType’s Pancreatic Cancer Risk Assessment Test, showing Test Showed Nearly 50% Improvement In Traditional Clainical Risk Score In Identifying Patients At High Risk

 Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to announce the publication of a peer-reviewed

GENE